HuGENet™ Publication Table
A Network of Investigator Networks in Human Genome Epidemiology
TABLE 1: International network-registries in human genome epidemiology
| Field |
Network-registry |
Type* |
No. of teams (no. in thousands)† |
Principal contact(s) |
|---|---|---|---|---|
Parkinson Disease |
Genetic Epidemiology of Parkinson Disease (GEO-PD) consortium |
D (CC>C) |
18 (10) |
D. M. Maraganore (dmaraganore@mayo.edu) |
HIV‡ infection |
International Meta-Analysis of HIV Host Genetics |
D (C>CC) |
30 (7) |
T. R. O'Brien (obrient@exchange.nih.gov) |
Cardiovascular disease |
Fibrinogen Studies Collaboration and Emerging Risk Factors Collaboration (new genetics component being launched) |
D (C) |
50 (200) |
J. Danesh (john.danesh@phpc.cam.ac.uk) |
Craniofacial anomalies |
Craniofacial anomalies network developed by the International Collaborative Research on Craniofacial Anomalies Project |
D (CC) |
9 (4) |
J. Little (jlittle@uottawa.ca) Internet Web address: www.who.int/genomics/anomalies/cfaproject/en/#mtg |
Osteoporosis |
Genetic Markers for Osteoporosis (GENOMOS) |
D (C>CC) |
10 (30) |
A. G. Uitterlinden (a.g.uitterlinden@erasmusmc.nl) |
Antiphospholipid syndrome |
International Meta-analysis of Antiphospholipid Syndrome Genetics |
D (CC>C) |
9 (4) |
J. P. A. Ioannidis (jioannid@cc.uoi.gr) |
Child growth and metabolism |
Birth Cohorts Consortium |
D (C) |
24 (55) |
M.-R. Jarvelin (m.jarvelin@imperial.ac.uk) |
Preterm birth |
Preterm Birth International Collaborative (PREBIC)/Preterm Birth and Genetics International Alliances (PREGENIA) |
D (C, CC) |
10 (20) |
|
Cancer, cardiovascular diseases, diabetes, aging |
European Prospective Investigation on Cancer, chronic diseases and nutrition (EPIC) |
D, E (C) |
521 (120) |
E. Riboli (riboli@iarc.fr) |
Lymphoma |
International Lymphoma Epidemiology Consortium (InterLymph) |
D (CC>C) |
15 (20) |
P. Hartge (ph43v@nih.gov), P. Boffetta (boffetta@iarc.fr) |
Lung cancer |
International Lung Cancer Consortium (ILCCO) |
D (CC>C) |
30 (51) |
R. Hung (hung@iarc.fr
) |
Head and neck cancer |
International Head and Neck Cancer Consortium (INHANCE) |
D (CC) |
13 (28) |
M. Hashibe (hashibe@iarc.fr) |
Melanoma |
Melanoma Genetics Consortium (GenoMel) |
D (CC) |
12 (3) |
J. A. Newton Bishop (j.newton-bishop@cancer.org.uk); Internet Web address: www.genomel.org |
Pancreatic cancer |
Pancreatic Cancer: Genetic Epidemiology (PACGENE) Consortium |
D (CC) |
10 (5) |
G. Petersen (peterg@mayo.edu) |
Breast cancer and prostate cancer |
Breast and Prostate Cancer and Hormone- Related Variants Cohort Consortium |
D (C) |
6 (13 + 20) |
D. Hunter (dhunter@hsph.harvard.edu) |
Brain tumors |
Brain Tumor Epidemiology Consortium (BTEC) |
D (CC) |
22 |
M. Bondy (mbondy@mdanderson.org), B. Malmer (beatrice.malmer@onkologi.umu.se) |
Breast cancer and colon cancer |
Breast and Colon Cancer Family Registries |
D |
10 (34 + 30) |
I. L. Andrulis, N. M. Lindor (seminard@mail.nih.gov
) |
Cancer |
Cancer Genetics Network (CGN)/Informatics Technology Group |
D (C) |
8 (24) |
C. Kasten (seminard@mail.nih.gov) |
Radiation and breast cancer |
Women's, Environmental, Cancer, and Radiation Epidemiology (WECARE) Study Consortium |
E (CC) |
15 (2) |
J. Bernstein (bernstej@mskcc.org) |
Environmental carcinogens |
International Collaborative Study on Genetic Susceptibility to Environmental Carcinogens (GSEC) |
E (CC) |
130 (58) |
|
Assisted reproduction |
International Pooled Analysis of Children Born after Assisted Procedures (APIKIDS) |
E (C) |
6 (7) |
|
DNA repair genes and cancer |
Web-based meta-analysis on DNA repair and cancer risk |
G (CC>C) |
5 |
P. Vineis (p.vineis@imperial.ac.uk) |
Other cancer-related networks |
D, G (C/CC) |
|||
Proposals for other networks |
Human Genome Epidemiology Network (HuGENet™) |
* D, disease-based network; CC>C, mostly case-control but also cohort studies included; C>CC, mostly cohort but also case-control studies included; C, cohort studies included; CC, case-control studies included; E, exposure-based network; G, gene-based network.
† In determining the number of teams, multicenter teams counted as one team, and the number of investigators may be much larger; numbers in parentheses show the approximate total number of subjects in the compiled databases.
‡ HIV, human immunodeficiency virus.
